Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.170
+0.090 (4.33%)
At close: Jan 21, 2025, 4:00 PM
2.230
+0.060 (2.76%)
After-hours: Jan 21, 2025, 7:04 PM EST
Stereotaxis Employees
Stereotaxis had 122 employees as of December 31, 2023. The number of employees decreased by 8 or -6.15% compared to the previous year.
Employees
122
Change (1Y)
-8
Growth (1Y)
-6.15%
Revenue / Employee
$206,090
Profits / Employee
-$187,648
Market Cap
183.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
STXS News
- 7 days ago - Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology - GlobeNewsWire
- 6 weeks ago - Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA - GlobeNewsWire
- 7 weeks ago - Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewsWire
- 7 weeks ago - Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha
- 2 months ago - Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewsWire
- 2 months ago - Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewsWire
- 2 months ago - Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript - Seeking Alpha